Canadian Stock Exchange (CSE) as BlissCo Cannabis Corp. (BLIS)
Frankfurt Stock Exchange (FRA) as BlissCo Cannabis Corp. (GQ4B:GR
Details on how US investors can buy BlissCo stock.
BlissCo Investor Relations contact: email@example.com
Press Releases and News
August 9, 2018
August 2, 2018
July 26, 2018
July 18, 2018
July 12, 2018
June 29, 3018
June 25, 2018
June 22, 2018
June 21, 2018
June 20, 2018
June 13, 2018
May 31, 2018
May 23, 2018
MAY 7, 2018
MAY 3, 2018
APRIL 12, 2018
APRIL 2, 2018
MARCH 06, 2018
MARCH 02, 2018
MARCH 02, 2018
FEBRUARY 26, 2018
As Canada is primed as a global leader and first mover in the cannabis industry, BlissCo is uniquely poised in the rapidly growing multi-billion dollar market and in various international markets as cannabis regulations progress.
BlissCo, founded in 2013, is a Canadian vertically integrated cultivation, extraction and distribution focused cannabis brand that earned its Access to Cannabis for Medical Purposes Regulations (ACMPR) license to cultivate from Health Canada on March 29, 2018.
BlissCo's state-of-the-art production facility, located in Metro Vancouver, is purposefully designed as a hub for research, cultivation, processing, extraction, packaging and distribution.
Now with the ACMPR license to cultivate, BlissCo will commence its operation to harvest premium cannabis within its' urban facility in Metro Vancouver. BlissCo also has a multi-year supply agreement in place with a Canadian Licensed Producer of characteristically sun-grown premium medicinal cannabis to purchase supply in large volumes (news release). This premium bulk cannabis will be brought to our secure and pristine facility in British Columbia for processing and then be packaged for sale and distribution to our growing patient list when BlissCo has appropriately received its license for sale.
BlissCo was founded with the assistance of a team of advisors, including medical and naturopathic doctors, has intentionally engaged with the medical community to understand how to contribute to improved patient health with medicinal cannabis products. A large part of our strategy for growth centres on how to securely integrate and collaborate with the healthcare system.
The BlissCo team has deep domain expertise in the critical category success areas:
Multi-province controlled substance distribution (BC and Alberta)
Cultivation and product safety, consistency and security
Indoor cultivation, controlled environments ensuring high standards & consistent products.
Quality assurance, product safety, 3rd Party GMP Audits & Certifications.
Strategic partnership with the Supreme Cannabis Company
Trading on Canadian Securities Exchange (CSE:BLIS)
ACMPR License to Produce earned
Cannabis plant starting material to arrive at BlissCo's facility and growing commences.
ACMPR Cannabis Oil Extraction License application submitted
Sign agreement to export 720 kilograms of medical cannabis to Germany
ACMPR License to Sell application submitted
Sign supply agreement with GreenSeal Cannabis
Sign e-commerce and technology service agreement with Namaste Technologies (TSXV: N)
Confirmation of Readiness for Inspection received from Health Canada
Confirmation of Readiness for License from Health Canada
Close on purchasing facility for $2.4m
Earn Building Permit from Township of Langley
ACMPR Licensed Submitted
Downloads and Links
BlissCo Cannabis Corp. CSE listing
BlissCo Cannabis Corp. Sedar filing information.
To learn more about investment opportunities please contact firstname.lastname@example.org.